We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Taste Test of a New Formulation of Sildenafil (Revatio)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00768573
First Posted: October 8, 2008
Last Update Posted: April 28, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Pfizer
  Purpose
taste of formulation

Condition Intervention Phase
None Volunteer Drug: sildenafil Phase 1

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®

Resource links provided by NLM:


Further study details as provided by Pfizer:

Primary Outcome Measures:
  • palatability (aroma, flavour texture and mouth feel) [ Time Frame: Duration of study. ]

Enrollment: 4
Study Start Date: January 2008
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1. Taste test
Not Specified
Drug: sildenafil
Oral suspension of sildenafil.

Detailed Description:
taste test None
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy volunteers
Criteria

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • History of hypersensitivity to test compounds or excipients.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00768573


Locations
United States, Massachusetts
Pfizer Investigational Site
Cambridge, Massachusetts, United States, 02140
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT00768573     History of Changes
Other Study ID Numbers: A1481257
First Submitted: September 4, 2008
First Posted: October 8, 2008
Last Update Posted: April 28, 2015
Last Verified: April 2015

Keywords provided by Pfizer:
taste test

Additional relevant MeSH terms:
Sildenafil Citrate
Vasodilator Agents
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Urological Agents